Charles Greg Guyer - 03 May 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
03 May 2024
Net transactions value
-$349,215
Form type
4
Filing time
07 May 2024, 17:58:28 UTC
Previous filing
19 Mar 2024
Next filing
14 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $16,818 +245 +0.31% $68.65 78,572 30 Apr 2024 Direct F1
transaction BMRN Common Stock Tax liability $366,034 -4,440 -5.7% $82.44 74,132 03 May 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.